[Distribution of intrathecally administered peroxidase in the guinea pig cochlea].

PubWeight™: 0.78‹?›

🔗 View Article (PMID 4678693)

Published in Arch Klin Exp Ohren Nasen Kehlkopfheilkd on January 01, 1972

Authors

K Jahnke

Articles citing this

[Fine structural studies on the permeability barriers of the inner ear (author's transl)]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1973) 0.92

Articles by these authors

(truncated to the top 100)

E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res (1991) 2.67

Expression of the gap-junction connexins 26 and 30 in the rat cochlea. Cell Tissue Res (1998) 1.58

The fine structure of freeze-fractured intercellular junctions in the guinea pig inner ear. Acta Otolaryngol Suppl (1975) 1.51

Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Ann Oncol (2007) 1.47

Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report. Neurology (2008) 1.44

[Ambulatory rehabilitation after cochlear prosthesis implantation]. HNO (2000) 1.40

[Osteosynthesis in facial bones: silicon nitride ceramic as material]. HNO (2006) 1.39

[Reconstruction of the superstructure of the stapes in guinea pigs with biovitro ceramic and silicone foil]. HNO (2002) 1.38

Prospective trial on topotecan salvage therapy in primary CNS lymphoma. Ann Oncol (2006) 1.17

Demonstration of identical clonal derivation in a case of "oculocerebral" lymphoma. Br J Ophthalmol (2005) 1.16

[Clinical studies on the effect of a new oral antidiabetic agent Glybenclamide (HB 419)]. Dtsch Med Wochenschr (1969) 1.15

Mutations in the connexin26/GJB2 gene are the most common event in non-syndromic hearing loss among the German population. Hum Mutat (2001) 1.12

Developmental expression patterns of connexin26 and -30 in the rat cochlea. Dev Genet (1999) 1.09

[Intercellular junctions in the guinea pig stria vascularis as shown by freeze-etching (author's transl)]. Anat Embryol (Berl) (1975) 0.97

[Lymphatic metastases of verrucous carcinoma (Ackerman tumor)]. HNO (1987) 0.97

[Prosthetic supply of tissue defects in head and neck surgery]. Laryngorhinootologie (2007) 0.96

PYD2 encodes 5,6-dihydropyrimidine amidohydrolase, which participates in a novel fungal catabolic pathway. J Mol Biol (2000) 0.96

[Fine structural studies on the permeability barriers of the inner ear (author's transl)]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1973) 0.92

Comparative investigation of the biocompatibility of various silicon nitride ceramic qualities in vitro. J Mater Sci Mater Med (2004) 0.90

Vascular variations of the inner ear. Acta Otolaryngol (2001) 0.90

Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the cervical oesophagus. Oncology (1999) 0.90

The blood-perilymph barrier. Arch Otorhinolaryngol (1980) 0.87

The permeability of blood vessels in the guinea pig cochlea. I. Vessels of the modiolus and spiral vessel. Anat Embryol (Berl) (1974) 0.85

[Patients' satisfaction after nasal septal and turbinate surgery. Results of a questionnaire]. Laryngorhinootologie (2007) 0.84

[Ambulatory surgery in the otorhinolaryngology, head and neck surgery specialty--combined scientific medical position of the German Society of Otorhinolaryngology, Head and Neck Surgery e.V., the German Professional Society of Otorhinolaryngologists e.V. and the Working Group of ENT Directors]. Laryngorhinootologie (2000) 0.84

[Golden tube wire for temporary or permanent implantation]. HNO (1996) 0.84

[Mucormycosis in paranasal sinuses]. HNO (2009) 0.83

[Aminoglycoside- and cisplatin-ototoxicity: from basic science to clinics]. Laryngorhinootologie (2004) 0.83

Acid base catalytic mechanism of the dihydropyrimidine dehydrogenase from pH studies. J Biol Chem (1993) 0.83

[Cutaneous basosquamous cell carcinoma]. HNO (2008) 0.82

Does metal coating improve the durability of silicone voice prostheses? Acta Otolaryngol (2001) 0.82

E-cadherin as a functional marker of the differentiation and invasiveness of squamous cell carcinoma of the head and neck. Clin Otolaryngol Allied Sci (1994) 0.82

[Biocompatibilty of silicon nitride ceramic in vitro. A comparative fluorescence-microscopic and scanning electron-microscopic study]. Laryngorhinootologie (2004) 0.82

The permeability of blood vessels in the guinea pig cochlea. II. Vessels in the spiral ligament and the stria vascularis. Anat Embryol (Berl) (1974) 0.82

[The pathogenesis of the acute symptoms of Menière's disease (author's transl)]. Laryngol Rhinol Otol (Stuttg) (1977) 0.81

[Investigations of carbohydrate and fat metabolism in pre-diabetes]. Diabetologia (1968) 0.81

Neomycin as secondary prophylaxis for irinotecan-induced diarrhea. Ann Oncol (2004) 0.81

[Meniere disease as an autosome dominant hereditary disease]. Laryngorhinootologie (1995) 0.81

[Smoking promotes the formation of peritonsillar abscesses]. Laryngorhinootologie (2005) 0.81

[Proceedings: Electron microscopy studies on the absorption of proteins from the endolymph]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1973) 0.80

[Progress in microsurgery of the middle ear]. HNO (1987) 0.80

[Long-term results of laser-tonsillotomy in obstructive tonsillar hyperplasia]. Laryngorhinootologie (2004) 0.80

[Hyperfractionated accelerated simultaneous radiochemotherapy in advanced hypopharyngeal carcinomas. Survival rate, retained function quality of life in a phase II study]. HNO (1998) 0.80

[Hypacusis in acquired hypothyroidism (author's transl)]. HNO (1979) 0.80

Freeze-fracture studies on the perilymph-endolymph barrier in experimentally induced hydrops. Arch Otorhinolaryngol (1985) 0.80

Chemo-radiotherapy for locally advanced head and neck cancer--long-term results of a phase II trial. Eur J Cancer (1997) 0.79

[Permeability barriers of the inner ear. Fine structure and function]. Fortschr Med (1980) 0.79

[Influence of weight reduction on carbohydrate and fat metabolism and on serum insulin response in obesity]. Diabetologia (1968) 0.79

Response of relapsed or refractory primary central nervous system lymphoma (PCNSL) to topotecan. Neurology (2004) 0.79

[Critical evaluation of vascular embolization in patients with Rendu-Osler disease]. Laryngorhinootologie (1997) 0.78

Porcine recombinant dihydropyrimidine dehydrogenase: comparison of the spectroscopic and catalytic properties of the wild-type and C671A mutant enzymes. Biochemistry (1998) 0.78

Purification and characterization of dihydropyrimidine dehydrogenase from Alcaligenes eutrophus. Arch Biochem Biophys (1996) 0.78

Purification, characterization, and kinetics of porcine recombinant dihydropyrimidine dehydrogenase. Protein Expr Purif (1997) 0.78

[Laser-tonsillotomy, state of the art and open questions]. Laryngorhinootologie (2005) 0.78

Effects of norepinephrine, theophylline and dibutyryl cyclic AMP on in vitro lipolysis of human adipose tissue in obesity. Diabetologia (1972) 0.77

[Case report of epithelioid hemangioendothelioma of the frontal region metastatic to the parotid gland]. Laryngorhinootologie (1998) 0.77

Coincidence of normal tension glaucoma, progressive sensorineural hearing loss, and elevated antiphosphatidylserine antibodies. Br J Ophthalmol (2004) 0.77

[Introduction of interdisciplinary prostate cancer centers based on the recommendations of the German Cancer Society. A cost-benefit analysis 3 years after accreditation]. Urologe A (2011) 0.77

Biocompatibility testing of new polymers in a moving implant bed. ORL J Otorhinolaryngol Relat Spec (2000) 0.77

Extrusion of middle ear implants. Clin Otolaryngol Allied Sci (1987) 0.77

Freeze-fracture study of taste bud pores in the foliate papillae of the rabbit. Cell Tissue Res (1979) 0.77

Experiences with Al2O3--ceramic middle ear implants. Biomaterials (1983) 0.76

[Connexin26 and -30 in the Cochlea and their clinical relevance]. Laryngorhinootologie (2001) 0.76

The effect of insulin on the uptake of radioactive labelled plasma triglycerides by rat tissue in vivo. Diabetologia (1967) 0.76

The fine structure of the cochlear plexus. Arch Otorhinolaryngol (1980) 0.76

[Management of iatrogenic esophageal perforations]. HNO (2007) 0.76

[Reconstruction of the tympanic membrane applying cartilage: indications, techniques and results]. HNO (2005) 0.76

Post-tonsillectomy haemorrhage: a retrospective comparison of abscess- and elective tonsillectomy. Acta Otolaryngol (2005) 0.75

[Fine structural demonstration of acetylcholinesterase activity in taste buds of rabbit foliate papillae. I. Morphological studies]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1972) 0.75

[Lermoyez syndrome. Clinical aspects and follow-up]. HNO (1989) 0.75

Bilateral peritonsillar abscesses. Eur Arch Otorhinolaryngol (2005) 0.75

[The time span between symptom onset and starting treatment in head and neck tumors]. HNO (1996) 0.75

Ceramic implants in otologic surgery. Am J Otol (1981) 0.75

[Long-term results following cholesteatoma surgery]. Laryngol Rhinol Otol (Stuttg) (1985) 0.75

Aluminium oxide ceramic implants in middle ear surgery. Clin Otolaryngol Allied Sci (1981) 0.75

Tragal cartilage in the primary reconstruction of defects resulting from a nasal septal abscess. Clin Otolaryngol Allied Sci (1995) 0.75

[The reaction of the human middle ear mucosa to the implantation of plastics. A light and electronmicroscopic study]. Laryngol Rhinol Otol (Stuttg) (1982) 0.75

[Wegener's granulomatosis and orbital complications of sino-nasal origin]. Laryngorhinootologie (2007) 0.75

[On the conformaton of macroglobulins. II. Acid dissociation and mercaptoethanol denaturation]. Klin Wochenschr (1965) 0.75

[In Process Citation]. Laryngorhinootologie (2016) 0.75

[Space-occupying lesion of the nasal septum in a patient with left-sided facial pain. Mucocele of the septum]. HNO (2002) 0.75

[Aminoglycoside toxicity. Pathomechanisms, clinical management and means of prevention]. HNO (2003) 0.75

[Histological criteria and metastasis of squamous cell carcinoma of the pinna]. Laryngorhinootologie (2005) 0.75

Secondary tritium and solvent deuterium isotope effects as a probe of the reaction catalyzed by porcine recombinant dihydropyrimidine dehydrogenase. Biochemistry (1998) 0.75

[Endoscopically controlled dilatative puncture tracheostomy]. HNO (1997) 0.75

[On the build change of newborn infants of diabetic mothers]. Dtsch Med Wochenschr (1966) 0.75

[Recommendations for the Provincial Chambers of Physicians of the Federal Republic of Germany on the handling of applications for authorization to conduct continuing education in ENT specialty]. Laryngorhinootologie (2001) 0.75

Experimental results concerning the reconstruction of the stapes superstructure with bioactive ceramics. Rev Laryngol Otol Rhinol (Bord) (1995) 0.75

[Squamous cell carcinoma of the external ear. A carcinoma of old age which requires individualized therapy planning]. HNO (2004) 0.75

[The optical rotatory dispersion of electrophoretically isolated paraproteins. I. On group specificity of normal and pathologic gamma globulins]. Klin Wochenschr (1966) 0.75

[Local antibiotic administration decreases risk of inner ear damage in effodation]. Laryngorhinootologie (2000) 0.75

A prospective evaluation of the Essen titanium stapes prosthesis. Clin Otolaryngol (2005) 0.75

[Einbecker recommendations of the German Society of Medical Law (DGMR) e. V]. Laryngorhinootologie (2008) 0.75

[Unusual nasal foreign body. Hardened concrete as a nasal foreign body]. HNO (1998) 0.75

[Macroglossia as the initial symptom of amyloidosis]. HNO (1995) 0.75

Basosquamous carcinoma--a rare but aggressive skin malignancy. J Plast Reconstr Aesthet Surg (2009) 0.75

Accelerated hyperfractionated radiotherapy with concurrent chemotherapy in locally advanced nasopharyngeal carcinoma: a phase II study. J Cancer Res Clin Oncol (2001) 0.75

[Interesting case no. 10. Cholesteatoma with destruction of the sigmoid sinus after thrombosis, with epidural abscess and Benzold abscesses]. Laryngorhinootologie (1998) 0.75

[Accelerated hyperfractionated radiotherapy with concurrent chemotherapy in locally advanced nasopharyngeal carcinomas]. HNO (2007) 0.75

[Brachytherapy with (192)Iridium in the treatment of recurrent nasopharyngeal carcinoma]. Laryngorhinootologie (2002) 0.75